Anna Perdrix Rosell
   HOME

TheInfoList



OR:

Anna Perdrix Rosell is a Spanish scientist who completed her PhD in cancer cell signalling at the
Francis Crick Institute The Francis Crick Institute (formerly the UK Centre for Medical Research and Innovation) is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Impe ...
in London. She co-founded a biotech start-up, which helped her get onto the Forbes 30 under 30 list in 2018."Sixfold Bioscience"
''Forbes''
"From Dinosaurs To Bionic Limbs: The 2018 Europe 30 Under 30 In Science And Healthcare"
''Forbes''


Early life and education

Perdrix Rosell grew up in Northern Spain, where she first learned to operate a microscope at the age of 5. Her father owned a company developing pest control methods for agriculture and he and Perdrix Rosell would collect samples to analyse together."New talent: the rising stars of culture, science and food 2019"
''The Observer''
Perdrix Rosell is studying for a PhD in Ilaria Malanchi's lab at the
Francis Crick Institute The Francis Crick Institute (formerly the UK Centre for Medical Research and Innovation) is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Impe ...
in London and Victoria Sanz-Moreno's lab at
King's College London King's College London (informally King's or KCL) is a public research university located in London, England. King's was established by royal charter in 1829 under the patronage of King George IV and the Duke of Wellington. In 1836, King's ...
. She studies how cancer cells can signal to other cells around it in the tumour microenvironment, which could potentially help a tumour grow.


Research and career

In the second year of her PhD, Perdrix Rosell co-founded a biotech start-up, Sixfold Bioscience, alongside fellow PhD student George Foot and Zuzanna Brzosko, who completed her PhD neuroscience from the University of Cambridge. The company aims to improve the way gene therapies are delivered to cancer cells, using RNA
nanotechnology Nanotechnology, also shortened to nanotech, is the use of matter on an atomic, molecular, and supramolecular scale for industrial purposes. The earliest, widespread description of nanotechnology referred to the particular technological goal o ...
."Homepage"
"Sixfold Bioscience"
They use customizable RNA
nanoparticles A nanoparticle or ultrafine particle is usually defined as a particle of matter that is between 1 and 100 nanometres (nm) in diameter. The term is sometimes used for larger particles, up to 500 nm, or fibers and tubes that are less than 1 ...
to get drugs into tumours, without harming nearby healthy cells. Perdrix Rosell said she started the company because "we wanted to build something to deliver cancer drugs only to diseased cells – minimising side effects and increasing the drugs' efficacy.""The Francis Crick Institute: Two Years On"
''Cancer Research UK''
The co-founders moved to the US for 3 months at the beginning of 2018 to take the company through the top US accelerator programme, Y Combinator. Sixfold Bioscience secured seed funding from Silicon Valley investors and was short-listed for the first Accelerate@Babraham start-up competition in July 2018. Perdrix Rosell was picked as the rising star of 2019 in science by The Observer. She also made it onto Forbes 30 under 30 list for European science and healthcare in 2018. And was named 100 Women Founder in Europe to follow on Twitter and LinkedIn."100 Women Founders In Europe To Follow On Twitter And LinkedIn"
''Forbes''


References

{{DEFAULTSORT:Perdrix Rosell, Anna Living people Cell biologists Cancer researchers Cancer research Year of birth missing (living people) Academics of the Francis Crick Institute